Tirzepatide is a synthetic peptide designed to interact with both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. It has been extensively investigated as a dual incretin-receptor agonist and is used in research examining receptor signalling, glucose-regulated cellular responses, metabolic pathway activity, and incretin biology.

• GLP-1 and GIP receptor signalling studies
• Incretin pathway research
• Glucose-responsive cellular signalling models
• Insulin secretion pathway analysis
• Metabolic receptor co-activation studies

This product has not been evaluated by SAHPRA and is not intended to diagnose, treat, cure, or prevent any disease. For research use only. Not for human or animal consumption. Not a drug, food additive, cosmetic, or dietary supplement.